NEW YORK (GenomeWeb) – The GenomeWeb Index rose nearly 4 percent in May as companies' fortunes largely depended on the strengths or weaknesses of their first quarter earnings reports.

The Index significantly outperformed the Dow Jones Industrial Average, which gained less than a tenth of a percent during the month, but was roughly in line with the Nasdaq, which gained nearly 4 percent, and the Nasdaq Biotechnology Index, which finished the month a little more than 4 percent higher.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.